How Transdermal Drug Delivery Works: A Plain-English Guide

What "Transdermal" Actually Means

Transdermal drug delivery means moving a medication through the skin and into the bloodstream so it can act on the whole body. The word breaks down neatly: "trans" means across, and "dermal" refers to the skin. So a transdermal patch is a device designed to carry a drug across the skin barrier and into systemic circulation.

It's worth separating this from a related idea that often gets confused with it. A topical product — like a hydrocortisone cream for a rash — is meant to act right where you put it, on or just under the skin's surface. A transdermal product is different: the skin is just the entry point, and the real target is somewhere else in the body entirely. A nicotine patch on your arm isn't treating your arm; it's delivering nicotine into your blood so it reaches your brain. That distinction — local versus systemic — is the whole point of transdermal delivery.

You've almost certainly encountered these products. Nicotine patches for quitting smoking, hormone patches for birth control or menopause, fentanyl and other pain patches, motion-sickness patches worn behind the ear, and nitroglycerin patches for chest pain are all well-established, regulator-approved transdermal medicines. They work, they're studied, and they've been refined over decades. That track record is exactly why the patch format is appealing for other compounds too — and also why it's easy to overestimate what any given patch can do. Understanding how the delivery actually works makes it much easier to tell a plausible product from an implausible one.

The Skin Is a Barrier, Not a Sponge

The single most important thing to understand about transdermal delivery is that your skin is designed to keep things out. It is not a sponge that soaks up whatever you put on it. It's one of the body's primary defenses against the outside world, and evolution spent a very long time making it good at that job.

Skin has three broad layers. The deepest is the subcutaneous tissue, mostly fat. Above it sits the dermis, which contains blood vessels, nerves, and structures like hair follicles and sweat glands. On top is the epidermis, and the outermost sliver of the epidermis is the layer that matters most for drug delivery: the stratum corneum.

The stratum corneum is often described with a "brick and mortar" analogy. The "bricks" are flattened, dead skin cells, and the "mortar" is a dense matrix of lipids (fats) packed between them. This thin layer — only about as thick as a sheet of paper — is astonishingly effective at blocking the passage of most substances. For a drug to reach the bloodstream through intact skin, it generally has to dissolve into and diffuse through that lipid mortar, then continue down into the living epidermis and the dermis, where blood vessels can finally pick it up and sweep it into circulation.

This is why transdermal delivery is hard, and why relatively few drugs are sold as patches. The barrier that protects you from the environment is the same barrier a patch has to get a drug across, and it doesn't make exceptions just because a molecule would be therapeutically useful on the other side.

How a Patch Actually Moves a Drug Across Skin

Given that skin resists penetration, how does a patch get anything through at all? The answer, for most conventional patches, is passive diffusion driven by a concentration difference.

A patch holds a reservoir of drug at a high concentration pressed against the skin. On the other side of the skin barrier, in the tissue and blood, the concentration of that drug is essentially zero to start. Nature abhors that imbalance: molecules always tend to move from where they're crowded to where they're sparse. So the drug slowly diffuses out of the patch, works its way through the stratum corneum, and moves into the tissue below, where blood vessels carry it away — which keeps the concentration on that side low and keeps the gradient pulling more drug across. As long as the patch stays on and full, that steady one-way flow continues.

There's a helpful side effect of sealing a patch against skin, too. Covering the skin traps moisture and warmth underneath — an effect called occlusion — which hydrates the stratum corneum and loosens its tightly organized lipids, making it modestly more permeable than dry, exposed skin. That's a real, physical assist, though a limited one.

The great advantage of this whole mechanism is steadiness. A swallowed pill produces a spike in blood levels as it's absorbed, then a decline as it's cleared, so levels rise and fall between doses. A patch, by contrast, can maintain a relatively flat, continuous drug level for hours or days. For some medications, that smooth delivery means fewer side effects and more consistent effect. It also means the drug never passes through the digestive system or the liver's aggressive first-pass metabolism before reaching circulation, which for certain drugs preserves much more of the active compound.

The Different Types of Patches

Not all patches are built the same way, and the engineering matters. Reviews of transdermal technology generally describe four main designs.

The drug-in-adhesive patch is the simplest and most common. The drug is dissolved directly into the sticky adhesive layer, so the same layer both holds the medicine and attaches to your skin. These are thin, flexible, and comfortable, which is why so many modern patches use this design.

The reservoir patch keeps the drug in a separate compartment — a small pouch of gel or liquid — behind a rate-controlling membrane. That membrane acts like a metering valve, releasing the drug at a controlled, predictable pace. The trade-off is that damaging the membrane could release the dose too quickly.

The matrix patch embeds the drug in a solid polymer layer (the matrix), which sits over a separate adhesive. The drug diffuses out of the matrix gradually. It's a middle ground between the simplicity of drug-in-adhesive and the control of a reservoir.

The micro-reservoir patch is a hybrid, containing many tiny drug compartments dispersed within a polymer, combining features of the reservoir and matrix approaches.

For someone evaluating a product, the takeaway isn't to memorize these categories — it's to recognize that a legitimate transdermal product is a piece of engineered pharmaceutics, not just "a sticker with an ingredient in it." The design exists to control how much drug crosses the skin and how fast.

Which Molecules Can Actually Cross Skin

Here's the part that separates a workable patch from wishful thinking. Because the stratum corneum is such a selective barrier, only molecules with the right physical properties can pass through it by simple diffusion.

Decades of research have produced a widely cited rule of thumb. First, size: a molecule generally needs to be small, with a molecular weight commonly cited as under about 500 Daltons, to cross skin effectively. Larger molecules simply can't thread their way through the tightly packed barrier. Second, solubility balance: the molecule needs to be lipophilic enough (oil-loving) to dissolve into the fatty mortar of the stratum corneum, but not so oil-loving that it gets stuck there and never moves on into the watery tissue beneath. It needs a balance.

This is why the roster of patch-delivered drugs is short and specific. Nicotine, fentanyl, nitroglycerin, and various hormones all happen to have the right combination of small size and suitable solubility. Many other useful drugs — including most large biologic drugs and many charged or strongly water-loving compounds — fail one or both tests and cannot be delivered through intact skin passively, no matter how much you'd like them to be.

This rule is also the honest test to apply to any supplement or "natural" patch. It doesn't matter how beneficial a compound is if swallowed; the question for a patch is specifically whether that molecule can physically cross human skin at a meaningful dose. A charged, water-loving molecule is exactly the kind that struggles, regardless of how good it looks in an oral study.

When the Molecule Doesn't Cooperate: Enhancement Methods

Because so many compounds fail the basic skin-crossing criteria, researchers have developed ways to help drugs across — with varying degrees of success and complexity.

Chemical penetration enhancers are substances added to a formulation to temporarily loosen the stratum corneum's lipid structure, making it more permeable. Certain alcohols, fatty acids, and surfactants can do this. They can improve absorption modestly, but there's a built-in tension: the more aggressively an enhancer disrupts the skin barrier, the more likely it is to cause irritation.

Beyond chemistry, there are physical and active methods that essentially force or create pathways through the skin. Microneedles are arrays of tiny needles that create microscopic channels in the stratum corneum without reaching the nerves that cause pain, allowing larger molecules through. Iontophoresis uses a mild electrical current to push charged drug molecules across the skin. Other approaches under study include electroporation, ultrasound (sonophoresis), and thermal ablation. These active methods can deliver molecules that passive patches never could — but they require devices, add cost and complexity, and are mostly found in clinical or advanced research settings rather than in a simple adhesive patch.

The reason this matters for a consumer is subtle but important: a plain adhesive patch with no enhancement technology is relying on passive diffusion alone. If the compound in it doesn't naturally cross skin well, no amount of marketing changes the underlying physics. Real enhancement is engineering, and engineering shows up in data, not just claims.

A Real-World Example: Why Some Compounds Struggle

To make this concrete, consider a compound like berberine, a plant alkaloid studied for metabolic effects. On paper, its molecular weight — around 336 Daltons — clears the 500-Dalton size threshold, so you might expect it to cross skin easily. But it fails the second test badly: berberine carries a permanent positive charge and is fairly water-loving, exactly the profile that resists passing through the lipid barrier of the stratum corneum.

This is why the science around transdermal berberine patches is so instructive. The most-cited data comes from a 2018 study in rats, where a transdermal berberine formulation reached roughly 3.6 times the blood levels of oral berberine — an encouraging signal, but one measured in rat skin, which is more permeable than human skin, and measuring blood levels rather than any health outcome.

The broader lesson generalizes to any patch-delivered supplement. Whether a compound crosses human skin at a useful dose is an empirical question that has to be answered with human data for that specific compound and that specific formulation. "Patches work" is true in general and misleading in particular. If you want to understand what's realistic for a given product, the useful questions are: does this molecule have skin-friendly chemistry, does the patch use any genuine enhancement technology, and is there human data — not rodent data — showing it actually gets in? You can read more about how this plays out for one popular ingredient in our non-prescription berberine option explainer.

Bottom Line

Transdermal drug delivery is a real, well-established, and genuinely clever technology. A patch works by holding a drug at high concentration against the skin so it diffuses steadily across the stratum corneum — the skin's paper-thin but formidable barrier — and into the bloodstream below, providing smooth, continuous dosing that bypasses the digestive system and the liver's first-pass metabolism.

But the same barrier that makes skin protective makes transdermal delivery selective. As a rule, only small molecules (roughly under 500 Daltons) with a good balance of oil- and water-solubility cross easily. Large, strongly charged, or very water-loving compounds struggle, which is why the list of patch-delivered drugs is short and specific rather than open to anything. Enhancement methods — chemical enhancers, microneedles, electrical currents — can extend what's possible, but they're real engineering that shows up in data, not just on a label.

The practical takeaway is a healthy skepticism paired with genuine appreciation. When a patch is built around a molecule with the right chemistry and backed by human data, it's an excellent delivery system. When a patch is built around a compound that fights the skin barrier and offers only animal data or marketing claims, the physics doesn't bend to the promise. Knowing the difference is what lets you evaluate any transdermal product — prescription or supplement — on its merits. As always, talk to your doctor before starting any new medication or supplement.

Related Articles

• What Is a Berberine Patch and Does It Work Like GLP-1?
• The Complete Guide to Berberine for Weight Loss
• Berberine vs. Ozempic: The Honest Comparison
• Purisaki Berberine Patches Review 2026